Article Details
Retrieved on: 2024-04-28 09:39:06
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Today, Novo Nordisk holds roughly 60% of the GLP-1 market share, largely thanks to Ozempic. However, the Danish pharmaceutical company has shown that ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here